Status: Recruiting
Phase III DAS181 Lower Tract PIV Infection in Immunocompromised Subjects (Substudy: DAS181 for COVID-19): RCT Study
This study will seek to enroll immunocompromised patients with Lower Tract parainfluenza infection. It also contains a sub-study to enroll patients with severe COVID-19.
Participants needed: 274
Trial details
Phase: Phase 3Biological sex: AllType: InterventionalSponsor: Ansun Biopharma, Inc.Updated: Jun 23, 2026Locations: 28
Eligibility criteria
At the time of randomization, requires supplemental oxygen ≥2 LPM due to hypoxem... [+16]
Subjects may not be on hospice care or, in the opinion of the investigator, have... [+14]